Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Published Online
on August 10, 2009

Hypertension. 2009
Published online before print August 10, 2009, doi: 10.1161/HYPERTENSIONAHA.109.135152
A more recent version of this article appeared on October 1, 2009
This Article
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
54/4/868    most recent
HYPERTENSIONAHA.109.135152v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Ohtsubo, T.
Right arrow Articles by Iida, M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ohtsubo, T.
Right arrow Articles by Iida, M.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*Protein
*UniGene
*Compound via MeSH
*Substance via MeSH
Related Collections
Right arrow Animal models of human disease
Right arrow Risk Factors
Right arrow Genetically altered mice
Right arrow Lipid and lipoprotein metabolism

Submitted on April 29, 2009
Revised on May 25, 2009

Xanthine Oxidoreductase Depletion Induces Renal Interstitial Fibrosis Through Aberrant Lipid and Purine Accumulation in Renal Tubules

Toshio Ohtsubo*; Kiyoshi Matsumura; Kanae Sakagami; Koji Fujii; Kazuhiko Tsuruya; Hideko Noguchi; Ilsa I. Rovira; Toren Finkel; and Mitsuo Iida

From the Department of Medicine and Clinical Science (T.O., K.M., K.S., K.F., K.T., H.N., M.I.), Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan; Translational Medicine Branch (I.R., T.F.), National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, Md.

* To whom correspondence should be addressed. E-mail: tohtsubo{at}intmed2.med.kyushu-u.ac.jp.

Abstract—Xanthine oxidoreductase (XOR) is an enzyme responsible for purine degradation, reactive oxygen species production, and adipogenesis. XOR gene-disrupted (XOR-/-) mice demonstrate renal failure and early death within several months. The aim of this study was to elucidate the mechanism of renal damage in XOR-/- mice and to determine the physiological role of XOR in the kidney. Histological analysis revealed that renal tubular damage in XOR-/- mice was accompanied by deposition of crystals and lipid-rich substances. Triglyceride content in renal homogenates was significantly increased in XOR-/- mice. The level of lipogenesis-related gene expression was comparable in XOR+/+ and XOR-/- mice, whereas the expression of adipogenesis-related gene expression was significantly elevated in XOR-/- mice. Urinary excretions of xanthine and hypoxanthine were markedly elevated in XOR-/- mice. Immunohistochemical analysis, Western blotting, and real time RT-PCR revealed that various markers of fibrosis, inflammation, ischemia, and oxidative stress were increased in XOR-/- mice. Finally, we demonstrate that primary renal epithelial cells from XOR-/- mice are more readily transformed to myofibroblasts, which is a marker of increased epithelial mesenchymal transition. These results suggest that XOR gene disruption induced the depletion of uric acid and the accumulation of triglyceride-rich substances, xanthine, and hypoxanthine in the renal tubules. We believe that these changes contribute to a complex cellular milieu characterized by inflammation, tissue hypoxia, and reactive oxygen species production, ultimately resulting in renal failure through increased renal interstitial fibrosis.


Key words: xanthine oxidoreductase • lipid • uric acid • xanthine • renal interstitial fibrosis • epithelial mesenchymal transition • oxidative stress